Prognostic role of body composition in peritoneal carcinomatosis patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy

被引:0
|
作者
Young Song
Myung Il Bae
Dong Woo Han
Eun Jung Park
Sujung Park
Sung Yeon Ham
机构
[1] Yonsei University College of Medicine,Department of Anesthesiology and Pain Medicine
[2] Yonsei University College of Medicine,Anesthesia and Pain Research Institute
[3] Yonsei University College of Medicine,Division of Colon and Rectal Surgery, Department of Surgery
关键词
Bioelectrical impedance analysis; Hyperthermic intraperitoneal chemotherapy; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Impact of the Peritoneal Surface Disease Severity Score in Patients with Sarcomatosis Undergoing Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
    Salti, G.
    Undevia, S.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S147 - S147
  • [22] Prognostic Analysis of Clinical and Biological Factors in Patients with Peritoneal Mesothelioma Treated by Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
    Deraco, M.
    Villa, R.
    Daidone, M. G.
    Baratti, D.
    Kusamura, S.
    Motta, R.
    Venturini, L.
    Zaffaroni, N.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 85 - 85
  • [23] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis
    Khan, Hadi M.
    Hanif, Hamza
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (02): : 259 - 261
  • [24] Long-term survival after cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with peritoneal carcinomatosis of urachal cancer
    Mertens, Laura S.
    Behrendt, Mark A.
    Mehta, Akash M.
    Boot, Jeroen de Jong Henk
    Stokkel, Laura
    van der Heijden, Michiel S.
    Horenblas, Simon
    Moonen, Luc M.
    Verwaal, Vic J.
    Meinhardt, Wim
    van Rhijn, Bas W. G.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (10) : 615 - 616
  • [25] Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis
    Nesher, Eviatar
    Greenberg, Ron
    Avital, Shmuel
    Skornick, Yehuda
    Schneebaunn, Schlomo
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2007, 9 (11): : 787 - 790
  • [26] Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study
    Solaini, Leonardo
    D'Acapito, Fabrizio
    Passardi, Alessandro
    Framarini, Massimo
    Tauceri, Francesca
    Di Pietrantonio, Daniela
    Frassineti, Giovanni Luca
    Gardini, Andrea Casadei
    Cucchetti, Alessandro
    Cavaliere, Davide
    Ercolani, Giorgio
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2019, 17 (1)
  • [27] Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study
    Leonardo Solaini
    Fabrizio D’Acapito
    Alessandro Passardi
    Massimo Framarini
    Francesca Tauceri
    Daniela Di Pietrantonio
    Giovanni Luca Frassineti
    Andrea Casadei Gardini
    Alessandro Cucchetti
    Davide Cavaliere
    Giorgio Ercolani
    [J]. World Journal of Surgical Oncology, 17
  • [28] Clinical practice guideline on peritoneal carcinomatosis treatment using surgical cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy
    Kavanagh, Melanie
    Ouellet, Jean-Francois
    [J]. BULLETIN DU CANCER, 2006, 93 (09) : 867 - 874
  • [29] Peritoneal carcinomatosis from colorectal cancer: hyperthermic intraperitoneal chemotherapy and the role of systemic chemotherapy
    Michael, Michael
    [J]. COLORECTAL CANCER, 2013, 2 (05) : 449 - 457
  • [30] Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma
    Begossi, G
    Gonzalez-Moreno, S
    Ortega-Perez, G
    Fon, LJ
    Sugarbaker, PH
    [J]. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2002, 28 (01): : 80 - 87